News
Bausch Health Companies, Inc. will become the new name of Valeant Pharmaceuticals International, Inc., effective in July…
Practical Dermatology® magazine and Modern Aesthetics® magazine have recognized the most popular online content …
One of the most widely anticipated approvals in 2017 was for Dupixent (dupilumab, Regeneron Pharmaceuticals, Inc.) injec…
Cutaneous warts are one of the most common and difficult conditions we treat in dermatology. The unfortunate fact is tha…
Steven Leon MS, PA-C and Gennady Rubinstein, MD, FAAD
With more than 329,000 new cases in the US every year, Lyme disease is one of the fastest-growing infectious diseases in…
Q&A with Sunjya K. Schweig, MD
When people travel on vacations, they tend to bring home souvenirs, photographs and memories. Sometimes, they also bring…
Franchesca Choi, RPh, MD; Candidate; Natasha Mesinkovska, MD, PhD; and Manuel Valdebran, MD
Onychomycosis is estimated to account for about half of all patient visits related to a nail dystrophy. According to Mol…
Paul Winnington, Editorial Director
George Washington University (GW) researchers have found that topically applied nitric oxide-releasing nanoparticles (NO…
